title: [Scalp cooling for chemotherapy-induced alopecia].
abstract: Alopecia is a very common side effect of cytostatic therapy and is considered one of the most emotionally distressing effects. To prevent alopecia scalp cooling is currently used in some indications in medical oncology in 59 hospitals in the Netherlands. The success of scalp cooling depends on various factors such as type of chemotherapy, dose, infusion time, number of treatment cycles and combinations of drugs. In general, scalp cooling is well tolerated. The reported side-effects are headache, coldness, dizziness and sometimes claustrophobia. An increase in the risk of scalp metastases has not been demonstrated. Proceeding from the South Netherlands Comprehensive Cancer Centre a national working group is put together in order to draw up a national guideline for chemotherapy-induced alopecia.
authors.affiliation: Medisch Centrum Alkmaar, afd. Oncologie, Alkmaar, the Netherlands. manon.komen@mca.nl
authors.forename: Marion M C
authors.initials: MM
authors.lastname: Komen
authors.forename: Carolien H
authors.initials: CH
authors.lastname: Smorenburg
authors.forename: Corina J G
authors.initials: CJ
authors.lastname: van den Hurk
authors.forename: J W R Hans
authors.initials: JW
authors.lastname: Nortier
mesh_terms: D000505:Alopecia / Q000139:chemically induced* / Q000517:prevention & control*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D007036:Hypothermia, Induced; D009369:Neoplasms / Q000188:drug therapy; D012535:Scalp / Q000502:physiology*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents